tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Steven Seedhouse, 276 are a BUY (94.52%), 14 are a HOLD (4.79%), 2 are a SELL (0.68%).
Analyst Steven Seedhouse, currently employed at RAYMOND JAMES, carries an average stock price target met ratio of 41.09% that have a potential upside of 66.7% achieved within 336 days.
Steven Seedhouse’s has documented 518 price targets and ratings displayed on 35 stocks. The coverage is on Healthcare, Industrials sectors.
Most recent stock forecast was given on DYN, Dyne Therapeutics at 25-Aug-2025.
Analyst best performing recommendations are on ARCT (ARCTURUS THERAPEUTICS HOLDINGS).
The best stock recommendation documented was for NTLA (INTELLIA THERAPEUTICS) at 6/29/2021. The price target of $168 was fulfilled within 2 days with a profit of $16.39 (10.81%) receiving and performance score of 54.05.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
$205
$22.5 (12.33%)
4 years 3 months 24 days ago
(05-May-2021)
3/5 (60%)
$35.09 (20.65%)
938
Hold
$173
$-9.5 (-5.21%)
$156
4 years 3 months 26 days ago
(03-May-2021)
14/24 (58.33%)
$2.73 (1.60%)
682
Hold
$190
4 years 4 months 3 days ago
(26-Apr-2021)
9/11 (81.82%)
$34.41 (22.12%)
350
Hold
$166
$-16.5 (-9.04%)
$175
4 years 6 months 25 days ago
(04-Feb-2021)
23/23 (100%)
$10.41 (6.69%)
828
Buy
$155
4 years 7 months 22 days ago
(07-Jan-2021)
7/7 (100%)
$36.79 (31.12%)
395
Which stock is Steven Seedhouse is most bullish on?
Which stock is Steven Seedhouse is most reserved on?
What Year was the first public recommendation made by Steven Seedhouse?
